BU-NOT-SET

CONTACT US
Science-led OSD reformulation
  • Drug product
  • Manufacturing
woman in lab
Case study
De-risking complex generic OSD development
  • Development
  • Drug product
woman in lab
Case study
Science-led OSD development
  • Development
  • Drug product
lady in lab with PPE
Insight
Advanced deformulation for complex generic development
  • Drug product
  • Manufacturing
three scientists in laboratory
White paper
How to turn development challenges into predictable outcomes
  • Development
  • Drug product
two scientists in laboratory
Webinar
Managing risk as high-potency manufacturing scales
  • Drug product
white powder
Insight
Safely scaling high potency API manufacturing
  • Drug product
api white powder
Insight
A predictive approach to complex OSD development
  • Development
  • Drug product
OSD development
eBook
Predictable development for uneventful manufacturing
  • Development
Development Services Recipharm
Video
Insight
  • Industry trends
Manufacturing Chemist CDMO roundtable – part one
Insight
  • Industry trends
  • Manufacturing
Increased drive to outsource manufacturing in life science
Insight
  • Manufacturing
Serialisation: the final countdown
Insight
  • Drug product
For lyophilisation, excipients really do matter
Insight
  • Manufacturing
The challenges of serialisation
Insight
  • Drug substance
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
Insight
  • Manufacturing
Strategies to prepare for serialisation
Insight
  • Drug substance
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones